Pacific Biosciences of California, Inc. ( PACB) - Key Metrics
PACB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.13 | -$0.14 | -$0.26 | -$0.27 |
| 2026Q1 | $0.12 | -$0.03 | -$0.15 | -$0.16 |
| 2025Q4 | $0.15 | -$0.13 | -$0.06 | -$0.07 |
| 2025Q3 | $0.13 | -$0.13 | -$0.06 | -$0.06 |
| 2025Q2 | $0.13 | -$0.14 | -$0.10 | -$0.10 |
PACB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.00 |
| 2026Q1 | 0% | -11.00 |
| 2025Q4 | 0% | -3.60 |
| 2025Q3 | 0% | -2.46 |
| 2025Q2 | 0% | -2.21 |
PACB
Price: $2.33
52 week price:
Earnings Per Share: -0.42 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 5.8 million
Ebitda: -20.1 millionMarket Capitalization: 838.6 million